Status | Study |
Not yet recruiting |
Study Name: Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma Condition: Resectable Pancreatic Duct Adenocarcinoma Date: 2016-11-03 Interventions: Drug: FOLFOX neoadjuvant chemotherapy |
Recruiting |
Study Name: Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS Condition: DCIS Ductal Carcinoma in Situ Date: 2016-09-19 Interventions: Other: Guideline Concordant Care |
Not yet recruiting |
Study Name: Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ Condition: Ductal Carcinoma In Situ Date: 2016-08-30 Interventions: Procedure: Sentinel lymph node biopsy (SLNB) Intervention is defined as that the DCIS patient has underg |
Recruiting |
Study Name: Clinical Outcome of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast Condition: Breast Cancer Date: 2016-08-25 Interventions: Drug: Single agent of cyclophosphamide, doxorubicin, epirubicin, fluorouraci |
Recruiting |
Study Name: Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy Condition: Carcinoma, Ductal, Breast Menopausal Date: 2015-10-12 Interventions: Device: Cryoablation Other Name: Cryotherapy |
Recruiting |
Study Name: Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (BEVABEL) Condition: Collecting Duct Carcinoma (Kidney) Date: 2015-02-09 Interventions: Drug: Bevacizumab Patients will be treated for a maximum o |
Active, not recruiting |
Study Name: Effects of Diet and Exercise on Ductal Carcinoma in Situ Condition: Ductal Carcinoma In Situ Breast Cancer Date: 2014-08-19 Interventions: Behavioral: Active Comparator: Progressive Resistance Training (PRT) and a h |
Active, not recruiting |
Study Name: A Feasibility Study for Women Receiving Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma Condition: Breast Cancer Date: 2014-05-12 Interventions: Other: Feasibility study All participants will have blood draws for biomarkers during the course of the |
Recruiting |
Study Name: Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer Condition: Breast Cancer Ductal Carcinoma in Situ Date: 2014-04-28 Interventions: Drug: Intranasal Oxytocin Intranasal spray, one spray or 4 IU of oxytocin will be administered into each |
Recruiting |
Study Name: Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer Condition: Carcinoma, Ductal, Breast Date: 2013-05-14 Interventions: Procedure: Biopsy before and after three weeks of study treatment |